Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-19-001802)

Filing Details

Accession Number:: 0001140361-19-001802
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-01-30 07:32:24
Reporting Period:: 2019-01-29

Accepted Time:: 2019-01-30 07:32:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1228627	Rexahn Pharmaceuticals Inc.	RNN	Pharmaceutical Preparations (2834)	113516358

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1375884	J Douglas Swirsky	C/O Rexahn Pharmaceuticals, Inc. 15245 Shady Grove Road, Suite 455 Rockville MD 20850	President And Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-01-29	50,000	$0.63	50,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price of $0.6344 per share represents a weighted average of purchase prices ranging from $0.6097 to $0.6386 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.